Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Raymond

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Neuroendocrinology|March 9, 2018
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine NeoplasmsAnna Pellat, Chantal Dreyer, Camille Couffignal, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patientsJacques Medioni, Gael Deplanque, Jean-Marc Ferrero, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2026
The effectiveness of telemonitoring, either self-administered or professionally assisted, in cancer care management: a descriptive, retrospective, observational cohort studySophie Martin, Aurélie Fritsch, Christelle Jouannaud, et al.
Epigenetics|July 31, 2015
Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive featuresGabriel G Malouf, Tomomitsu Tahara, Valérie Paradis, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group StudyEric Raymond, Alba A Brandes, Christian Dittrich, et al.
Liver Cancer|August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver CancersJames J Harding, Ahmad Awada, Gael Roth, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Neuroendocrinology|March 9, 2018
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine NeoplasmsAnna Pellat, Chantal Dreyer, Camille Couffignal, et al.
Therapeutic Advances in Medical Oncology|April 7, 2023
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncologyVladimir Lazar, Baolin Zhang, Shai Magidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2014
Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patientsJacques Medioni, Gael Deplanque, Jean-Marc Ferrero, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2026
The effectiveness of telemonitoring, either self-administered or professionally assisted, in cancer care management: a descriptive, retrospective, observational cohort studySophie Martin, Aurélie Fritsch, Christelle Jouannaud, et al.
Epigenetics|July 31, 2015
Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive featuresGabriel G Malouf, Tomomitsu Tahara, Valérie Paradis, et al.
British Journal of Cancer|April 7, 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpressionThomas Decaens, Carlo Barone, Eric Assenat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group StudyEric Raymond, Alba A Brandes, Christian Dittrich, et al.
Liver Cancer|August 11, 2022
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver CancersJames J Harding, Ahmad Awada, Gael Roth, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumorsVladimir Lazar, Eric Raymond, Shai Magidi, et al.
BJU International|August 30, 2012
Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failureHielke J Meulenbeld, Jean P Bleuse, Elio M Vinci, et al.
Pageof 18